BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 38656879)

  • 1. Integrated bioinformatics combined with machine learning to analyze shared biomarkers and pathways in psoriasis and cervical squamous cell carcinoma.
    Liu L; Yin P; Yang R; Zhang G; Wu C; Zheng Y; Wu S; Liu M
    Front Immunol; 2024; 15():1351908. PubMed ID: 38863714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune cell infiltration and prognostic index in cervical cancer: insights from metabolism-related differential genes.
    Ma B; Ren C; Yin Y; Zhao S; Li J; Yang H
    Front Immunol; 2024; 15():1411132. PubMed ID: 38840928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell index-based RiskScore model for predicting prognosis in thyroid cancer and experimental verification.
    Chen R; Gao W; Liang L; Yu H; Song W
    Heliyon; 2024 Jun; 10(11):e31970. PubMed ID: 38868069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M2 macrophages regulate KDM6B/PFKFB2 metabolic reprogramming of cervical squamous cell carcinoma through CXCL1.
    Yu J; Huang L; Cao L
    Cell Mol Biol (Noisy-le-grand); 2024 Jun; 70(6):78-84. PubMed ID: 38836678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Expression Analysis for Uterine Cervix and Corpus Cancer Characterization.
    Almorox L; Antequera L; Rojas I; Herrera LJ; Ortuño FM
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell and Bulk Transcriptomic Analyses Reveal a Stemness and Circadian Rhythm Disturbance-related Signature Predicting Clinical Outcome and Immunotherapy Response in Hepatocellular Carcinoma.
    Zhu X; Zhang Z; Zhang J; Xiao Y; Wang H; Wang M; Jiang M; Xu Y
    Curr Gene Ther; 2024 Jun; ():. PubMed ID: 38847249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome profiling of cancer and normal tissues from cervical squamous cancer patients by deep sequencing.
    Lin W; Feng M; Li X; Zhong P; Guo A; Chen G; Xu Q; Ye Y
    Mol Med Rep; 2017 Aug; 16(2):2075-2088. PubMed ID: 28656315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cellular Senescence-Related Signature Predicts Cervical Cancer Patient Outcome and Immunotherapy Sensitivity.
    Shao H; Li X; Wu P; Chen Z; Zhang C; Gu H
    Reprod Sci; 2023 Dec; 30(12):3661-3676. PubMed ID: 37580647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.
    Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J
    Front Immunol; 2024; 15():1244392. PubMed ID: 38694506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Wang Y; Han Y; Jin L; Ji L; Liu Y; Lin M; Zhou S; Yang R
    Aging (Albany NY); 2024 Apr; 16(8):7293-7310. PubMed ID: 38656879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Cancer Stem Cell Characteristics and Development of a Prognostic Stemness Index Cell-Related Signature in Oral Squamous Cell Carcinoma.
    Feng J; Li Y; Wen N
    Dis Markers; 2021; 2021():1571421. PubMed ID: 34840626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
    Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.